Turbovas-F Tablet
Marketer
Micro Labs Ltd
Salt Composition
Fenofibrate (160mg) + Rosuvastatin (10mg)
Overview Turbovas-F Tablet
LipiComb tablets combine two lipid-reducing agents to lower elevated cholesterol and triglyceride levels in the blood. This medication is prescribed when dietary modifications (such as a low-fat diet) prove insufficient. It contributes to a reduced risk of cardiovascular disease. LipiComb can be administered with or without food, at any time of day, but consistent daily timing is recommended for adherence. Dosage is determined by your physician based on lipid levels and treatment response. While high cholesterol and triglycerides often present without symptoms, discontinuing treatment can worsen the condition and elevate the risk of heart disease and stroke. Regular lipid profile monitoring is essential. This medication is part of a comprehensive treatment plan including a heart-healthy diet, regular exercise, smoking cessation, moderate alcohol consumption, and weight management. Maintain a balanced diet while taking this medication, minimizing high-fat foods. Common, generally mild, side effects include nausea, abdominal discomfort, constipation, headache, flatulence, and myalgia, typically resolving spontaneously. Persistent side effects, jaundice, unusual bleeding or bruising, or severe or recurrent muscle pain warrant immediate medical attention. Periodic liver function tests may be recommended. This medicine is contraindicated in hepatic impairment (e.g., abnormal liver function tests, persistent jaundice). Inform your physician of any renal issues, pregnancy, pregnancy planning, or breastfeeding. Diabetic patients should carefully monitor blood glucose levels, as this medication may cause hyperglycemia.
Uses of Turbovas-F Tablet
Cardiovascular event prevention and hypercholesterolemia management
Major Benefits of Turbovas-F Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Turbovas-F Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Turbovas-F Tablet:
- Headache
- Muscle pain
- Constipation
- Abnormal liver function tests
- Joint pain
- Elevated creatine kinase
- Diabetes
How to use Turbovas-F Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Turbovas-F Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
How Turbovas-F Tablet works:
Lipitrol Duo tablets combine fenofibrate and rosuvastatin, two medications that reduce blood lipids. Fenofibrate decreases triglyceride levels, and rosuvastatin inhibits the production of low-density lipoprotein (LDL) cholesterol. Concurrently, both medications increase high-density lipoprotein (HDL) cholesterol levels.
SAFETY ADVICE
AlcoholUNSAFE
Combining Turbovas-F Tablet with alcohol is strongly discouraged due to safety concerns.
PregnancyUNSAFE
The use of Turbovas-F Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal and human studies has revealed substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Use of Turbovas-F Tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Turbovas-F Tablet.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Turbovas-F Tablets, potentially requiring dosage modification. A physician's consultation is advised. Turbovas-F Tablets are contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Turbovas-F Tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. Turbovas-F Tablets are contraindicated for individuals with severe or active liver disease.
What if you forget to take Turbovas-F Tablet :
Should you forget a Turbovas-F Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Turbovas-F Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |






